Full-Time
Posted on 6/14/2024
Develops drugs for muscle function improvement
$139k - $169kAnnually
Mid
San Bruno, CA, USA
Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.
Company Stage
IPO
Total Funding
$1.2B
Headquarters
South San Francisco, California
Founded
1998
Help us improve and share your feedback! Did you find this helpful?